Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing intensive follow-up care with standard care for patients with non-severe pulmonary embolism.

Official title: Evaluation of the Efficacy of Intensive Medical Follow-up with an Advanced Practice Nurse Compared with Medical Follow-up Alone, in Non-severe Pulmonary Embolism - Randomised Open Study At Dijon University Hospital and Langres University Hospital.

Run by Centre Hospitalier Universitaire Dijon · NCT06598930 · Data updated 2026-11-12

This study is testing whether more frequent check-ins with a nurse after being treated for non-severe pulmonary embolism can help patients do better than just regular follow-ups.

More Non-severe Pulmonary Embolism trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment360 (estimated)
SponsorCentre Hospitalier Universitaire Dijon
Academic / other
Locations1 site (Dijon)
StatusRecruiting
StartedDecember 11, 2024
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedDecember 18, 2024
Trial IDNCT06598930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who have been diagnosed with non-severe pulmonary embolism and are residents in the specified regions.

Probably not a fit

Patients who are not affiliated with a social security system or those under legal protection may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of intensive medical follow-up provided by an advanced practice nurse compared to standard medical follow-up for patients diagnosed with non-severe pulmonary embolism. The aim is to improve patient outcomes by reducing recurrence rates and complications associated with pulmonary embolism through enhanced monitoring and support. Participants will receive either routine follow-up or intensive follow-up after being discharged from the hospital. The study is conducted in France, focusing on patients treated at Dijon University Hospital or Langres University Hospital.

Why it matters

Potential benefit: If successful, this approach could lead to better management of non-severe pulmonary embolism, reducing recurrence and complications for patients.

How similar studies have gone: While similar approaches have been explored, this specific evaluation of intensive follow-up for non-severe pulmonary embolism is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Person who has given oral consent
* Person affiliated to the social security system
* Over 18 years of age
* Resident in the 21-52 region
* Emergency care at Dijon University Hospital or Langres University Hospital less than 24 hours after diagnosis of non-severe pulmonary embolism (spESI = 0)

Symptomatic PE is confirmed if there is :

* a high pre-test clinical probability and a high probability ventilation-perfusion (V/Q) lung scan according to the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) criteria
* a proximal DVT diagnosed by ultrasound in a patient with symptoms of PE;
* a positive CT pulmonary angiogram (PA) showing a central filling defect highlighted by contrast material or a complete occlusion in a segmental or more proximal pulmonary artery.
* No contraindication to anticoagulant treatment

Exclusion Criteria:

* Person not affiliated to or not benefiting from a social security scheme
* Person subject to a legal protection measure (curatorship, guardianship)
* Person subject to a legal protection measure
* Pregnant women, women in labour or breastfeeding mothers
* An adult who is incapable or unable to give consent
* Minors
* Contraindication to anticoagulant treatment

Where it's running

  • Chu Dijon Bourgogne
    Dijon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.